(S (NP (NP (JJ High-dimensional) (NNS biomarkers)) (PP (JJ such) (IN as) (NP (NNS genomics)))) (VP (VBP are) (ADVP (RB increasingly)) (VP (VBG being) (VP (VBN measured) (PP (IN in) (NP (JJ randomized) (JJ clinical) (NNS trials)))))) (. .))
(S (ADVP (RB Consequently)) (, ,) (NP (EX there)) (VP (VBZ is) (NP (NP (DT a) (VBG growing) (NN interest)) (PP (IN in) (S (VP (VBG developing) (NP (NP (NNS methods)) (SBAR (WHNP (WDT that)) (S (VP (VBP improve) (NP (DT the) (NN power) (S (VP (TO to) (VP (VB detect) (NP (JJ biomarker-treatment) (NNS interactions))))))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP adapt) (NP (NP (ADJP (RB recently) (VBN proposed)) (NN two-stage) (NN interaction)) (VP (VBG detecting) (NP (NNS procedures)) (PP (IN in) (NP (NP (DT the) (NN setting)) (PP (IN of) (NP (JJ randomized) (JJ clinical) (NNS trials)))))))) (. .))
(S (NP (PRP We)) (ADVP (RB also)) (VP (VBP propose) (NP (NP (DT a) (JJ new) (NN stage) (CD 1) (NN multivariate) (NN screening) (NN strategy)) (VP (VBG using) (NP (NN ridge) (NN regression)) (S (VP (TO to) (VP (VB account) (PP (IN for) (NP (NP (NNS correlations)) (PP (IN among) (NP (NNS biomarkers))))))))))) (. .))
(S (PP (IN For) (NP (DT this) (NN multivariate) (NN screening))) (, ,) (NP (PRP we)) (VP (VBP prove) (NP (NP (DT the) (JJ asymptotic) (NN between-stage) (NN independence)) (, ,) (VP (VBN required) (PP (IN for) (NP (DT the) (JJ family-wise) (NN error) (NN rate) (NN control))))) (, ,) (PP (IN under) (NP (DT the) (JJ biomarker-treatment) (NN independence)))) (. .))
(S (NP (NN Simulation) (NNS results)) (VP (VBP show) (SBAR (IN that) (S (PP (IN in) (NP (JJ various) (NNS scenarios))) (, ,) (NP (DT the) (NN ridge) (NN regression) (VBG screening) (NN procedure)) (VP (MD can) (VP (VB provide) (NP (NP (ADJP (RB substantially) (JJR greater)) (NN power)) (PP (IN than) (NP (DT the) (JJ traditional) (JJ one-biomarker-at-a-time) (NN screening) (NN procedure)))) (PP (IN in) (NP (ADJP (RB highly) (VBN correlated)) (NN data)))))))) (. .))
(S (NP (PRP We)) (ADVP (RB also)) (VP (VBP exemplify) (NP (PRP$ our) (NN approach)) (PP (IN in) (NP (CD two) (JJ real) (JJ clinical) (NN trial) (NNS data) (NNS applications)))) (. .))
